CN102406906A - Traditional Chinese medicine composition for treating acute hepatitis B - Google Patents
Traditional Chinese medicine composition for treating acute hepatitis B Download PDFInfo
- Publication number
- CN102406906A CN102406906A CN2011103717690A CN201110371769A CN102406906A CN 102406906 A CN102406906 A CN 102406906A CN 2011103717690 A CN2011103717690 A CN 2011103717690A CN 201110371769 A CN201110371769 A CN 201110371769A CN 102406906 A CN102406906 A CN 102406906A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- acute hepatitis
- treating acute
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention provides a traditional Chinese medicine composition for treating acute hepatitis B. The traditional Chinese medicine composition comprises the following original drugs by weight ratio: 15-25 parts of radix bupleuri, 25-35 parts of white peony root, 25-35 parts of Poria cocos, 15-25 parts of gynostemma pentaphylla, 10-20 parts of red sage root, 5-15 parts of magnolia cortex, 5-15 parts of Rhizoma Zingiberis Preparata, 5-15 parts of pinellia ternate, 15-25 parts of oriental wormwood, 15-25 parts of stringy stonecrop, 15-25 parts of turtle shell, 5-15 parts of Chinese Polyphaga and 5-15 parts of cattail pollen. The composition of the invention employs natural ingredients, and has the advantages of simple preparation, wide drug source and low cost.
Description
Technical field
The invention belongs to technical field of Chinese medicines, specifically be meant a kind of Chinese medicine composition of treating acute hepatitis B.
Background technology
Hepatitis B is caused, is served as main and can cause a kind of disease of multiple organ injury with the liver inflammatory lesion by hepatitis B virus (HBV).Primary disease is widely current in countries in the world, mainly invades child and person between twenty and fifty, and small number of patients can be converted into liver cirrhosis or hepatocarcinoma.Therefore, it has become the worldwide disease of serious threat human health, also is that China's current popular is the most extensive, the most serious a kind of disease of hazardness.Hepatitis B does not have certain popular phase, all can fall ill throughout the year, but distributes belong to more.
Acute hepatitis B is meant human body recent infection hepatitis B virus; Cause the immunne response of body; The process of replying tends to cause hepatocyte injury and destruction; Damage and destroy and will cause the hepatic tissue inflammation causes a series of symptoms and liver function test unusual, and the pathological changes of this hepatic tissue inflammation that causes owing to hepatitis B virus infection that takes place recently is exactly an acute hepatitis B.If protracted course of disease very easily transfers chronic hepatitis to.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine composition of treating acute hepatitis B.
The technical scheme that the present invention adopted is: a kind of Chinese medicine composition of treating acute hepatitis B; It is characterized in that this Chinese medicine composition is to adopt the medicine original thing of following weight proportion to form: Radix Bupleuri 15-25, Radix Paeoniae Alba 25-35, Poria 25-35, Herb Gynostemmae Pentaphylli 15-25, Radix Salviae Miltiorrhizae 10-20, Cortex Magnoliae Officinalis 5-15, Rhizoma Zingiberis Preparatum 5-15, Rhizoma Pinelliae 5-15, Herba Artemisiae Scopariae 15-25, Herba Sedi 15-25, Carapax Trionycis 15-25, eupolyphoge sinensis 5-15, Pollen Typhae 5-15.
What the traditional Chinese medical science was thought incidence of hepatitis is damp and hot heresy for getting the upper hand at all, and deficiency of vital QI is cause evil poison invasion basic, therefore should be that treatment is basic with the eliminating pathogenic factor for supporting vital QI when treatment.In the Chinese medicine composition provided by the present invention, Radix Bupleuri is evacuated and is brought down a fever the yang invigorating soothing liver-QI; Radix Paeoniae Alba nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing is received antiperspirant; The Poria eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, mind tranquilizing and the heart calming; The Herb Gynostemmae Pentaphylli QI invigorating is calmed the nerves, blood pressure lowering; The Radix Salviae Miltiorrhizae promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind; Cortex Magnoliae Officinalis circulation of qi promoting removing food stagnancy; Dampness is removed full; Lowering the adverse QI to relieve asthma; The Rhizoma Zingiberis Preparatum warming spleen and stomach for dispelling cold, warming the meridian for stopping bleeding. The capable water of the Rhizoma Pinelliae is wet, lowering the adverse flow of QI, and the kind taste damp-phlegm of dispelling; The Herba Artemisiae Scopariae clearing away damp-heat, the jaundice eliminating subcutaneous ulcer; The Herba Sedi eliminating damp-heat has the effect of the glutamate pyruvate transaminase of reduction; Carapax Trionycis nourishing kidney YANG hyperactivity suppressing, hard masses softening and resolving; Eupolyphoge sinensis removing blood stasis with potent drugs blood, reuniting the fractured tendons and bones; The Pollen Typhae hemostasis, blood stasis dispelling, treating stranguria.Above-mentioned all medicines share, and play the merit of clearing away heat-damp and promoting diuresis, eliminating turbid pathogen with aromatics, regulating qi and activating blood altogether, fundamentally reach the purpose of treatment acute hepatitis B.
Chinese medicinal composition provided by the present invention all adopts natural raw material of Chinese medicine, and its simple and convenient preparation, the medicine source is wide, cost is low.The present invention carries out the prescription compatibility according to the traditional Chinese medical science to the understanding mechanism of acute hepatitis B, and instructions of taking is after above-mentioned Chinese medicine composition is pulverized, and is packaged into the 3.5-5g/ bag, morning, noon and afternoon every day three mixing in water for oral taking, one time one bag.This Chinese medicine composition verifies that through clinical practice it is evident in efficacy, and the property of medicine is gentle, and is safe and reliable, has no side effect, and effective percentage reaches 92%.
The specific embodiment
Below in conjunction with embodiment the present invention is described further
Embodiment 1
A kind of Chinese medicine composition of treating acute hepatitis B; It is characterized in that this Chinese medicine composition is to adopt the medicine original thing of following weight proportion to form: Radix Bupleuri 20g, Radix Paeoniae Alba 30g, Poria 30g, Herb Gynostemmae Pentaphylli 20g, Radix Salviae Miltiorrhizae 15g, Cortex Magnoliae Officinalis 10g, Rhizoma Zingiberis Preparatum 10g, Rhizoma Pinelliae 10g, Herba Artemisiae Scopariae 20g, Herba Sedi 20g, Carapax Trionycis 20g, eupolyphoge sinensis 10g, Pollen Typhae 10g.
Embodiment 2
A kind of Chinese medicine composition of treating acute hepatitis B; It is characterized in that this Chinese medicine composition is to adopt the medicine original thing of following weight proportion to form: Radix Bupleuri 15g, Radix Paeoniae Alba 35g, Poria 25g, Herb Gynostemmae Pentaphylli 25g, Radix Salviae Miltiorrhizae 10g, Cortex Magnoliae Officinalis 15g, Rhizoma Zingiberis Preparatum 5g, Rhizoma Pinelliae 15g, Herba Artemisiae Scopariae 15g, Herba Sedi 25g, Carapax Trionycis 15g, eupolyphoge sinensis 15g, Pollen Typhae 5g.
Embodiment 3
A kind of Chinese medicine composition of treating acute hepatitis B; It is characterized in that this Chinese medicine composition is to adopt the medicine original thing of following weight proportion to form: Radix Bupleuri 25g, Radix Paeoniae Alba 25g, Poria 35g, Herb Gynostemmae Pentaphylli 15g, Radix Salviae Miltiorrhizae 20g, Cortex Magnoliae Officinalis 5g, Rhizoma Zingiberis Preparatum 15g, Rhizoma Pinelliae 5g, Herba Artemisiae Scopariae 25g, Herba Sedi 15g, Carapax Trionycis 25g, eupolyphoge sinensis 5g, Pollen Typhae 15g.
Embodiment 4
A kind of Chinese medicine composition of treating acute hepatitis B; It is characterized in that this Chinese medicine composition is to adopt the medicine original thing of following weight proportion to form: Radix Bupleuri 18g, Radix Paeoniae Alba 32g, Poria 28g, Herb Gynostemmae Pentaphylli 22g, Radix Salviae Miltiorrhizae 12g, Cortex Magnoliae Officinalis 12g, Rhizoma Zingiberis Preparatum 8g, Rhizoma Pinelliae 12g, Herba Artemisiae Scopariae 18g, Herba Sedi 22g, Carapax Trionycis 18g, eupolyphoge sinensis 12g, Pollen Typhae 8g.
Embodiment 5
A kind of Chinese medicine composition of treating acute hepatitis B; It is characterized in that this Chinese medicine composition is to adopt the medicine original thing of following weight proportion to form: Radix Bupleuri 22g, Radix Paeoniae Alba 28g, Poria 32g, Herb Gynostemmae Pentaphylli 18g, Radix Salviae Miltiorrhizae 18g, Cortex Magnoliae Officinalis 8g, Rhizoma Zingiberis Preparatum 12g, Rhizoma Pinelliae 8g, Herba Artemisiae Scopariae 22g, Herba Sedi 18g, Carapax Trionycis 22g, eupolyphoge sinensis 8g, Pollen Typhae 12g.
A kind of Chinese medicine composition of treating acute hepatitis B, clinical efficacy is summed up:
One, general data: this Chinese medicine composition is applied to clinical observation case 28 examples, wherein male 15 examples, and women 13 examples, at 18～52 years old age, the five indexes of hepatitis b inspection is small three positive.
Two, usage and dosage: during clinical practice, the component in the compositions, consumption are taken the circumstances into consideration increase and decrease according to patient's body weight, age and symptom.Material medicine is pulverized morning, noon and afternoon every day three mixing in water for oral taking, each 3.5-5g.
Three, criterion of therapeutical effect:
Weigh with the small three positive negative conversion rate.
(1) recovery from illness: three indexs are all turned out cloudy;
(2) produce effects: four-index in the small three positive: virus replication stops sign (HBeAb-hepatitis B virus e antibody) and turns out cloudy;
Four, therapeutic effect: in this clinical observation case, took medicine 3-6 month, 12 examples of fully recovering, produce effects 14 examples, toxic and side effects does not take place in invalid 2 examples during the treatment.
Five, model case:
Chu, the man, 41 years old, symptom: hepatalgia to occur violent for reason owing to dinner party is stayed up late too much, drunk etc. recently, and it is weak often to feel tired, and headache and dizzy is often liked couching, and evening, legs and feet also had the symptom that knots.
Inspection: the patient becomes thin, lassitude, complexion are gloomy pitch-dark, and palpation finds to have slight splenomegaly phenomenon, and liver size hardness is no abnormal, five indexes of hepatitis b 145 positives, and liver function detects multinomial exceeding standard.
Diagnosis: acute HBV infects.
Therapeutic scheme: lie up, alleviating alcohol addiction, light diet, and vitimin supplement C and vitamin B group etc. are taken Chinese medicine composition provided by the invention simultaneously.
Therapeutic effect: clinical symptoms complete obiteration after 3 months, HBV-DNA turns out cloudy, and liver function test is all normal.
Ma, 28 years old, the woman, in the recent period prominent sense insomnia and dreamful sleep, weak, detest greasy, appetite is little, hepatalgia, yellowing of the skin.Inspection: HBsAg (+), HBeAg (+), HBcAb (+).Liver function: ALT270u/L, AST248u/l, TBIL63.4umol/L, DBIL 23.1umol/L.HBVDNA：5.7*10E8cps/ml。
Diagnosis: acute hepatitis B.
Taking the present invention provides traditional Chinese medicine composition for treating after one month, and patient's clinical symptom disappearance was treated three months, and liver function recovery is normal, and HBVDNA drops to the 4.3*10E5 power.After 4 months, liver function is normal, and HBVDNA turns out cloudy.E antigen is turned out cloudy after half a year, and liver function is normal, and HBVDNA is negative.
Claims (1)
1. Chinese medicine composition of treating acute hepatitis B; It is characterized in that this Chinese medicine composition is to adopt the medicine original thing of following weight proportion to form: Radix Bupleuri 15-25, Radix Paeoniae Alba 25-35, Poria 25-35, Herb Gynostemmae Pentaphylli 15-25, Radix Salviae Miltiorrhizae 10-20, Cortex Magnoliae Officinalis 5-15, Rhizoma Zingiberis Preparatum 5-15, Rhizoma Pinelliae 5-15, Herba Artemisiae Scopariae 15-25, Herba Sedi 15-25, Carapax Trionycis 15-25, eupolyphoge sinensis 5-15, Pollen Typhae 5-15.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103717690A CN102406906A (en) | 2011-11-22 | 2011-11-22 | Traditional Chinese medicine composition for treating acute hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103717690A CN102406906A (en) | 2011-11-22 | 2011-11-22 | Traditional Chinese medicine composition for treating acute hepatitis B |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102406906A true CN102406906A (en) | 2012-04-11 |
Family
ID=45909441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011103717690A Pending CN102406906A (en) | 2011-11-22 | 2011-11-22 | Traditional Chinese medicine composition for treating acute hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102406906A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103211999A (en) * | 2013-05-03 | 2013-07-24 | 南京中医药大学 | Controlled-release pellet for treating acute and chronic hepatitis and preparation method and application thereof |
| CN106074961A (en) * | 2016-06-29 | 2016-11-09 | 韩秀山 | Acute hepatitis B adjusts the Chinese medicine composition of QI and blood toxin expelling |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1273832A (en) * | 2000-05-09 | 2000-11-22 | 黄志荣 | Compound Yexiazhu medicine and preparing process thereof |
| CN1421234A (en) * | 2002-12-13 | 2003-06-04 | 郭言勋 | Oral liquid for treating hepatitis B |
-
2011
- 2011-11-22 CN CN2011103717690A patent/CN102406906A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1273832A (en) * | 2000-05-09 | 2000-11-22 | 黄志荣 | Compound Yexiazhu medicine and preparing process thereof |
| CN1421234A (en) * | 2002-12-13 | 2003-06-04 | 郭言勋 | Oral liquid for treating hepatitis B |
Non-Patent Citations (6)
| Title |
|---|
| > 19970131 匡奕璜 中医中药诊治乙型病毒性肝炎述评 18-22 1 第28卷, 第1期 * |
| > 20040430 钟有添等 中医药治疗病毒性乙型肝炎研究进展 224-227 1 第24卷, 第2期 * |
| > 20060430 周庭前等 祛湿保肝汤为主治疗慢性乙型肝炎疗效观察 204-205 1 第22卷, 第4期 * |
| 匡奕璜: "中医中药诊治乙型病毒性肝炎述评", <<江西中医药>>, vol. 28, no. 1, 31 January 1997 (1997-01-31), pages 18 - 22 * |
| 周庭前等: "祛湿保肝汤为主治疗慢性乙型肝炎疗效观察", <<实用中医药杂志>>, vol. 22, no. 4, 30 April 2006 (2006-04-30), pages 204 - 205 * |
| 钟有添等: "中医药治疗病毒性乙型肝炎研究进展", <<赣南医学院学报>>, vol. 24, no. 2, 30 April 2004 (2004-04-30), pages 224 - 227 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103211999A (en) * | 2013-05-03 | 2013-07-24 | 南京中医药大学 | Controlled-release pellet for treating acute and chronic hepatitis and preparation method and application thereof |
| CN103211999B (en) * | 2013-05-03 | 2014-07-16 | 南京中医药大学 | Controlled-release pellet for treating acute and chronic hepatitis and preparation method and application thereof |
| CN106074961A (en) * | 2016-06-29 | 2016-11-09 | 韩秀山 | Acute hepatitis B adjusts the Chinese medicine composition of QI and blood toxin expelling |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102166317B (en) | Traditional Chinese medicine combination for curing metrorrhagia and metrostaxis | |
| CN103463500B (en) | Medicament for treating cerebral hemorrhage | |
| CN101327309A (en) | Chinese medicine for treating lymph cancer, nasopharyngeal carcinoma and brain cancer | |
| CN101745047A (en) | Chinese medicinal composition for treating gout disease and preparation method thereof | |
| CN103142920A (en) | Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof | |
| CN102512585B (en) | Traditional Chinese medicine used for treating yin deficiency and fire hyperactivity | |
| CN102406906A (en) | Traditional Chinese medicine composition for treating acute hepatitis B | |
| CN102228648B (en) | Chinese medicinal composition for treating icterohepatitis | |
| CN105617062A (en) | Traditional Chinese medicine composition used for treating lung cancer, and preparation method and applications thereof | |
| CN102949659A (en) | Traditional Chinese medicine composition for treating hepatitis B | |
| CN102764411B (en) | Drug composite for curing jaundice and preparation method thereof | |
| CN104547384A (en) | Oral liquid for treating paraquat poisoning and preparation method of oral liquid | |
| CN102406913A (en) | Chinese medicinal composition for treating melancholia | |
| CN103550681A (en) | Traditional Chinese medicine (TCM) composition for treating hepatitis B | |
| CN103495022B (en) | A kind of Chinese medicine of auxiliary treatment AIDS | |
| CN116350731B (en) | Formula for clearing heat, removing dampness and relieving arthralgia as well as preparation and application thereof | |
| CN102671032B (en) | Traditional Chinese medicine for treating recurrent aphthae | |
| CN101015671B (en) | Chinese patent drug for treating cirrhosis | |
| CN100998720B (en) | Oral traditional Chinese medicine for treating amenorrhea of uterus stasis | |
| CN1194722C (en) | Shugan Zhitong soft extract for treating hepatitis | |
| CN103638441A (en) | Traditional Chinese medicinal composition for treating fatty liver with liver stagnation and spleen deficiency symptom | |
| CN104352707A (en) | Traditional Chinese medicine pills for treating chloasma | |
| CN104096099A (en) | Traditional Chinese medicine composition for treating recurrent oral ulceration | |
| CN1352979A (en) | Chinese medicine for replenishing vital energy and promoting blood circulation | |
| CN103566235A (en) | Medicine for treating hepatitis B |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120411 |